Ligand validation:2POC

BG6: 6-O-phosphono-beta-D-glucopyranose

BG6 is a Ligand Of Interest in 2POC designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2POC_BG6_B_713	95%	49%	0.073	0.978	0.88	1.09	1	3	0	1	100%	1
2POC_BG6_C_713	94%	53%	0.079	0.976	1.17	0.65	2	-	0	1	100%	1
2POC_BG6_D_713	90%	46%	0.084	0.966	1.37	0.75	2	-	0	1	100%	1
2POC_BG6_A_713	67%	42%	0.142	0.95	1.08	1.16	2	2	0	1	100%	1
2PUW_BG6_B_713	59%	28%	0.168	0.952	1.66	1.24	3	4	1	1	100%	1
6HDK_BG6_A_308	100%	68%	0.037	0.995	0.44	0.77	-	-	0	0	100%	1
6HDM_BG6_A_304	100%	63%	0.038	0.994	0.51	0.9	-	-	0	0	100%	1
6HDL_BG6_A_301	100%	62%	0.047	0.992	0.44	0.99	-	1	0	0	100%	1
3ZI4_BG6_A_1220	99%	8%	0.055	0.987	2.07	2.47	2	7	0	0	100%	1
6I03_BG6_A_302	99%	69%	0.06	0.992	0.41	0.79	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.